Fred S. Zeidman, Director at Bluejay Diagnostics, Inc. (BJDX), bought 12,500 shares at $2.00 ($25K) on 2026-03-14, disclosed to the SEC on 2026-05-18.
Director Fred S. Zeidman purchased 12,500 shares at $2.00, signaling confidence in the company's recovery potential. This move comes as the stock has crashed 76.82% over the past year and is currently trading at its 52-week low of $1.66.
BJDX is currently trading at its 52-week low of $1.66, having lost 76.82% of its value over the last 12 months despite a slight 5.14% pullback in the past week.
A cluster of 4 other insiders bought shares in the last 30 days, indicating a coordinated accumulation effort.
The stock carries significant risk due to its ultra-low market capitalization of approximately $2 million and a short interest of 2.21% of the float, which could lead to volatility if the price rebounds.
Something here stands out, but not much.
| Filing → |
| STRP | SELL | 2017-06-19 | $898K | — | Filing → |
| HDY | BUY | 2012-05-31 | $9K | — | Filing → |